Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancerMOLECULAR ONCOLOGYIF4.52023-08-183OAAI
Germline and somatic genetic variability of oxysterol-related genes in breast cancer patients with early disease of the luminal subtypeBIOCHIMIEIF32022-08-017PRE
Imatinib-induced changes in the expression profile of microRNA in the plasma and heart of mice-A comparison with doxorubicinBIOMEDICINE & PHARMACOTHERAPYIF7.52019-07-0121OAAI
Development of high-resolution melting analysis for ABCB1 promoter methylation: Clinical consequences in breast and ovarian carcinomaONCOLOGY REPORTSIF3.92019-06-0512OAAI
Expression of oxysterol pathway genes in oestrogen-positive breast carcinomasCLINICAL ENDOCRINOLOGYIF2.42017-04-244PREAI
Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transportersTOXICOLOGY AND APPLIED PHARMACOLOGYIF3.42016-11-0196PREAI
Genetic and functional analyses do not explain the association of high PRC1 expression with poor survival of breast carcinoma patientsBIOMEDICINE & PHARMACOTHERAPYIF7.52016-10-0117PREAI
Transcript expression and genetic variability analysis of caspases in breast carcinomas suggests CASP9 as the most interesting targetCLINICAL CHEMISTRY AND LABORATORY MEDICINEIF3.72016-06-211PREAI
The association of taxane resistance genes with the clinical course of ovarian carcinoma紫杉烷耐药基因与卵巢癌临床病程的关系GENOMICSIF32013-08-0134PRE
Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progressionFUTURE ONCOLOGYIF2.62013-03-0812PREAI